158 related articles for article (PubMed ID: 15555623)
21. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L
Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554
[TBL] [Abstract][Full Text] [Related]
23. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
[TBL] [Abstract][Full Text] [Related]
24. Cell death induced by Pteris semipinnata L. is associated with p53 and oxidant stress in gastric cancer cells.
Liu Z; Ng EK; Liang NC; Deng YF; Leung BC; Chen GG
FEBS Lett; 2005 Feb; 579(6):1477-87. PubMed ID: 15733860
[TBL] [Abstract][Full Text] [Related]
25. Stress via p53 pathway causes apoptosis by mitochondrial Noxa upregulation in doxorubicin-treated neuroblastoma cells.
Kurata K; Yanagisawa R; Ohira M; Kitagawa M; Nakagawara A; Kamijo T
Oncogene; 2008 Jan; 27(6):741-54. PubMed ID: 17653088
[TBL] [Abstract][Full Text] [Related]
26. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
Shehata M; Shehata M; Shehata F; Pater A
Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
[TBL] [Abstract][Full Text] [Related]
27. Melittin inhibits vascular smooth muscle cell proliferation through induction of apoptosis via suppression of nuclear factor-kappaB and Akt activation and enhancement of apoptotic protein expression.
Son DJ; Ha SJ; Song HS; Lim Y; Yun YP; Lee JW; Moon DC; Park YH; Park BS; Song MJ; Hong JT
J Pharmacol Exp Ther; 2006 May; 317(2):627-34. PubMed ID: 16401728
[TBL] [Abstract][Full Text] [Related]
28. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
29. Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells.
Corbiere C; Liagre B; Terro F; Beneytout JL
Cell Res; 2004 Jun; 14(3):188-96. PubMed ID: 15225412
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
31. Balance of NF-kappaB and p38 MAPK is a determinant of radiosensitivity of the AML-2 and its doxorubicin-resistant cell lines.
Choi CH; Xu H; Bark H; Lee TB; Yun J; Kang SI; Oh YK
Leuk Res; 2007 Sep; 31(9):1267-76. PubMed ID: 17218010
[TBL] [Abstract][Full Text] [Related]
32. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
33. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
34. Tirapazamine cytotoxicity for neuroblastoma is p53 dependent.
Yang B; Reynolds CP
Clin Cancer Res; 2005 Apr; 11(7):2774-80. PubMed ID: 15814660
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the 53BP2S-mediated apoptosis by nuclear factor kappaB and Bcl-2 family proteins.
Takahashi N; Kobayashi S; Kajino S; Imai K; Tomoda K; Shimizu S; Okamoto T
Genes Cells; 2005 Aug; 10(8):803-11. PubMed ID: 16098144
[TBL] [Abstract][Full Text] [Related]
36. Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4.
Kurbanov BM; Fecker LF; Geilen CC; Sterry W; Eberle J
Oncogene; 2007 May; 26(23):3364-77. PubMed ID: 17160022
[TBL] [Abstract][Full Text] [Related]
37. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma.
Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N
Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273
[TBL] [Abstract][Full Text] [Related]
38. Cell surface-directed interaction of anthracyclines leads to cytotoxicity and nuclear factor kappaB activation but not apoptosis signaling.
Maestre N; Tritton TR; Laurent G; Jaffrézou JP
Cancer Res; 2001 Mar; 61(6):2558-61. PubMed ID: 11289131
[TBL] [Abstract][Full Text] [Related]
39. TNF-alpha promotes Doxorubicin-induced cell apoptosis and anti-cancer effect through downregulation of p21 in p53-deficient tumor cells.
Cao W; Chi WH; Wang J; Tang JJ; Lu YJ
Biochem Biophys Res Commun; 2005 May; 330(4):1034-40. PubMed ID: 15823547
[TBL] [Abstract][Full Text] [Related]
40. Transfection of a dominant-negative mutant NF-kB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm and p53.
Zhou M; Gu L; Zhu N; Woods WG; Findley HW
Oncogene; 2003 Nov; 22(50):8137-44. PubMed ID: 14603254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
